- Supported exchanges /
- NASDAQ /
- GUTS.NASDAQ
Fractyl Health, Inc. Common Stock (GUTS NASDAQ) stock market data APIs
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Fractyl Health, Inc. Common Stock Financial Data Overview
| 2.86 | |
| 2.98 | |
| - | |
| 3.14 | |
| 2.835 | |
| 1.74-15 | |
| 137 M | |
| 47 927 K | |
| 119 K | |
| -0.36 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Fractyl Health, Inc. Common Stock Fundamental Data is available in our Financial Data APIs
- Net Revenue 119 K
- EBITDA -71 014 000
- Earnings Per Share -1.37
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Fractyl Health, Inc. Common Stock Earnings via APIs
- Latest Release 2024-08-15
- EPS/Forecast -0.46
Get Fractyl Health, Inc. Common Stock End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
